生物制品板块1月8日涨0.58%，康辰药业领涨，主力资金净流入1.2亿元

Core Insights - The biopharmaceutical sector experienced a slight increase of 0.58% on January 8, with Kangchen Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4082.98, down 0.07%, while the Shenzhen Component Index closed at 13959.48, down 0.51% [1] Stock Performance - Kangchen Pharmaceutical (603590) closed at 44.39, up 5.99% with a trading volume of 103,600 shares and a transaction value of 453 million [1] - Olin Bio (616889) closed at 29.04, up 4.24% with a trading volume of 95,700 shares and a transaction value of 278 million [1] - Baike Bio (688276) closed at 20.23, up 3.80% with a trading volume of 63,700 shares and a transaction value of 128 million [1] - Wanze Co. (000534) closed at 21.58, up 3.25% with a trading volume of 121,950 shares and a transaction value of 475 million [1] - Other notable performers include Palin Bio (000403) and Wantai Bio (603392), with increases of 2.71% and 2.53% respectively [1] Fund Flow Analysis - The biopharmaceutical sector saw a net inflow of 120 million from institutional investors, while retail investors experienced a net outflow of 152 million [2] - Major stocks like Kangchen Pharmaceutical and Anke Bio had significant net inflows from institutional investors, indicating strong interest [3] - Kangchen Pharmaceutical had a net inflow of 52.07 million from institutional investors, while retail investors showed a net outflow of 78.11 million [3]